2014
DOI: 10.3233/jad-141470
|View full text |Cite
|
Sign up to set email alerts
|

Detecting Early Preclinical Alzheimer's Disease via Cognition, Neuropsychiatry, and Neuroimaging: Qualitative Review and Recommendations for Testing

Abstract: In this paper, we review studies that have investigated whether neuropsychological, neuropsychiatric, and neuroimaging measures predict decline to Alzheimer's disease (AD). Prospective neuropsychological studies indicate that cognitive performance may be an excellent indicator of future progression from mild cognitive impairment (MCI) to AD, particularly when episodic memory is combined with tasks relying on executive control and language tasks. Research on neuropsychiatric symptoms reveal that depression, apa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
62
0
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 92 publications
(65 citation statements)
references
References 79 publications
2
62
0
1
Order By: Relevance
“…This is consistent with the observation that MCI is mainly characterized by memory deficits [3,5], and that both episodic memory and working memory are impaired early in the disease process and are predictors of conversion from MCI to AD [11,36] (for a review, see [37]) and from healthy aging to MCI [38].…”
Section: Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…This is consistent with the observation that MCI is mainly characterized by memory deficits [3,5], and that both episodic memory and working memory are impaired early in the disease process and are predictors of conversion from MCI to AD [11,36] (for a review, see [37]) and from healthy aging to MCI [38].…”
Section: Discussionsupporting
confidence: 89%
“…One other crucial difference between the two studies is that we differentiated nonprogressor from progressor MCI. Some studies have indicated that executive functions and inhibition are more impaired in progressors than in non-progressor MCIs [20,21,43,47] and predictive models that are most sensitive and specific often include executive function measures [11] (for a review, see [37]). Our results support this literature as executive functions were found to differ between non-progressor and progressor MCI and only the latter showed increased impairment.…”
Section: Discussionmentioning
confidence: 99%
“…A large number of studies have examined the accuracy of cognitive tests to predict progression from MCI to AD, and studies have revealed that a range of episodic memory tests are excellent predictors of future decline. [27] AD is a progressive degenerative disorder of insidious onset, characterized, in its earliest stages, by declarative memory loss. Research diagnostic criteria for AD proposed by an expert consensus group led by Dubois set early and substantial impairment in episodic memory as core diagnostic criteria for AD.…”
Section: Discussionmentioning
confidence: 99%
“…Unfortunately, by the time patients meet criteria for dementia, the brain has suffered sufficient damage to severely impact cognition and autonomy. With this in mind, recognizing putative progress to dementia when patients experience only mild cognitive deficits, at a stage of Mild Cognitive Impairment (MCI), is paramount to develop disease-modifying therapies and identifying appropriate therapeutic windows [39]. Clinical studies with MCI patients have reported higher risk rates of conversion to dementia (in particularly to AD) than community studies, suggesting these patients as a group of singular interest to follow-up studies and interventions [10, 11].…”
Section: Introductionmentioning
confidence: 99%